Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios

Advanced Radiation Therapy Committee for the International Association for the Study of Lung Cancer

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Stereotactic body radiation therapy (SBRT) is an effective and well-tolerated treatment for medically inoperable patients with early stage NSCLC. SBRT is a noninvasive treatment involving the delivery of ablative radiation doses with high precision in the course of a few treatments. Relative to conventionally fractionated radiation, SBRT achieves superior local control and survival. SBRT use has increased dramatically in the past 15 years and is currently considered the standard of care in cases of inoperable early stage NSCLC. It is being increasingly applied to more complex patient populations at higher risk of treatment-related toxicity. In these more complex patients, there is an increasing need to balance patient and treatment factors in selecting the optimal patients for SBRT. Here, we review several challenging clinical scenarios often encountered in thoracic multidisciplinary tumor boards.

Original languageEnglish
Pages (from-to)1075-1085
Number of pages11
JournalJournal of Thoracic Oncology
Issue number7
StatePublished - Jul 2021


  • Interstitial lung disease
  • Non–small cell lung cancer
  • Oligometastatic
  • Reirradiation
  • Stereotactic body radiation therapy
  • Ultracentral


Dive into the research topics of 'Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios'. Together they form a unique fingerprint.

Cite this